Jan. 23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good ...
THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about ... plant in Framingham, Massachusetts. On Jan. 15, 2025 ...
In comparison, Massachusetts-based biotech companies ... TechFlash and Real Estate newsletters — all free. Sanofi’s Framingham facility hit with FDA warning ...
THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant ... at their Genzyme manufacturing plant in Framingham, ...
Agency cites contamination at Massachusetts plant where company ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi ...
(HealthDay News) — The US Food and Drug Administration (FDA) has warned Sanofi about significant ... their Genzyme manufacturing plant in Framingham, Massachusetts. On January 15, a warning ...
an anti-coagulant secreted in the milk of transgenic goats (Capra aegagrus hircus), GTC Biotherapeutics of Framingham, Massachusetts, finally secured US approval for Atryn as well, from CBER.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback